TrialEuropean journal of cancer (Oxford, England : 1990)2010

Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours.

Helen J Mackay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.